lysine has been researched along with n(6)-(1-carboxyethyl)lysine in 53 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (1.89) | 18.7374 |
1990's | 5 (9.43) | 18.2507 |
2000's | 23 (43.40) | 29.6817 |
2010's | 24 (45.28) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Miller, SP; Thompson, J | 1 |
Carlquist, M; Ghosh, D; Jörnvall, H; Krook, M; Strömberg, R | 1 |
Ahmed, MU; Baynes, JW; Brinkmann Frye, E; Degenhardt, TP; Thorpe, SR | 1 |
Kholodkova, EV; Kocharova, NA; Kochetkov, NK; Shashkov, AS; Shcherbakova, OV; Stanislavsky, ES | 1 |
Kaca, W; Kochetkov, NK; Paramonov, NA; Senchenkova, SN; Shashkov, AS; Toukach, FV; Ziolkowski, A | 1 |
Borisova, SA; Knirel, YA; Kocharova, NA; Shashkov, AS; Vinogradov, EV | 1 |
Bank, RA; Bayliss, MT; Baynes, JW; Bijlsma, JW; DeGroot, J; Lafeber, FP; Oldehinkel, E; Tekoppele, JM; Thorpe, SR; Verzijl, N | 1 |
Bank, RA; Baynes, JW; Bijlsma, JW; DeGroot, J; Lafeber, FP; Lyons, TJ; Shaw, JN; TeKoppele, JM; Thorpe, SR; Verzijl, N | 1 |
Ahmed, N; Argirov, OK; Cordeiro, CA; Minhas, HS; Thornalley, PJ | 1 |
Barja, G; Bellmun, MJ; Gredilla, R; Pamplona, R; Portero-Otín, M | 1 |
Barja, G; Gredilla, R; Pamplona, R; Portero-Otín, M; Requena, J | 1 |
Araki, T; Hayase, F; Hayashi, CM; Horiuchi, S; Nagai, R | 1 |
Barto, R; Lieuw-A-Fa, ML; Schalkwijk, CG; Stehouwer, CD; Teerlink, T; Twisk, J; van Hinsbergh, VW | 1 |
Cheriex, EC; Konings, CJ; Kooman, JP; Leunissen, KM; Schalkwijk, CG; Scheffer, PG; ter Wee, PM; van de Kerkhof, J; van der Sande, FM | 1 |
Barto, R; Schalkwijk, CG; Teerlink, T; Ten Brink, HJ | 1 |
Baynes, JW | 1 |
Boehm, BO; Kientsch-Engel, R; Lang, GE; Lang, GK; Rosinger, S; Schilling, S; Stahl, P | 1 |
Araki, T; Horiuchi, S; Koito, W; Nagai, R | 1 |
Chandoga, J; Futas, J; Jakus, V; Petrovic, R | 1 |
Bootsma, AH; Chaturvedi, N; Fuller, JH; Schalkwijk, CG; Schram, MT; Stehouwer, CD | 1 |
Schmitt, HP | 1 |
Amano, S; Fukayama, M; Kaji, Y; Nagai, R; Oshika, T; Takazawa, Y | 1 |
Baynes, JW; den Hollander, NC; Graaff, R; Mulder, DJ; Smit, AJ; Smit, GP; Thorpe, SR | 1 |
Bakker, SJ; Damman, K; Hartog, JW; Schalkwijk, CG; Scheijen, J; Smilde, TD; Smit, AJ; van Veldhuisen, DJ; Voors, AA | 1 |
Bijl, M; Bijzet, J; de Leeuw, K; Graaff, R; Kallenberg, CG; Nienhuis, HL; Schalkwijk, CG; Smit, A | 1 |
Desai, K; Dhar, A; Kazachmov, M; Wu, L; Yu, P | 1 |
Baumann, M; Eckstein, HH; Heemann, U; Kouznetsova, T; Pelisek, J; Richart, T; Roos, M; Sollinger, D; Staessen, JA | 1 |
Choi, YG; Lim, S | 1 |
't Hart, LM; Blaak, EE; de Groot, PG; Dekker, JM; Ferreira, I; Feskens, EJ; Gaens, KH; Heine, RJ; Nijpels, G; Schalkwijk, CG; Stehouwer, CD; van der Kallen, CJ; van Greevenbroek, MM | 1 |
Biemond, BJ; Brandjes, DP; Fijnvandraat, K; Nur, E; Otten, HM; Schalkwijk, CG; Schnog, JJ | 1 |
Hashim, Z; Zarina, S | 1 |
Ames, JM; Connolly, L; del Castillo, MD; Elliott, CT; Hull, GL; Srey, C | 1 |
Engelen, L; Ferreira, I; Hovind, P; Parving, HH; Persson, F; Rossing, P; Schalkwijk, CG; Stehouwer, CD; Teerlink, T | 1 |
Izumi, M; Maruyama, T; Mera, K; Nagai, R; Otagiri, M; Takeo, K | 1 |
Bialczak-Kokot, M; Knirel, YA; Kocharova, NA; Ovchinnikova, OG; Rozalski, A; Shashkov, AS | 1 |
Akileshwari, C; Muthenna, P; Reddy, GB | 1 |
Andrades, MÉ; Dal-Pizzol, F; Lorenzi, R; Moreira, JC; Nagai, R; Ritter, C | 1 |
Du, R; Jing, Y; Lu, L; Yang, K; Zhang, R; Zhu, J; Zhu, Z | 1 |
Lee, JA; Li, YC; Shih, YM | 1 |
Brimble, MA; Cooper, GJ; Woods, TM | 1 |
Engelen, L; Franssen, FM; Gopal, P; Reynaert, NL; Rutten, EP; Schalkwijk, CG; Scheijen, JL; Wouters, EF | 1 |
Dekker, JM; Engelen, L; Ferreira, I; Hanssen, NM; Huijberts, MS; Nijpels, G; Schalkwijk, CG; Scheijen, JL; Stehouwer, CD; van der Kallen, CJ; van Greevenbroek, MM | 1 |
Fahlgren, C; Forslund, A; Lindh, CH; Östman, E; Tareke, E | 1 |
Cheng, L; Dai, M; Jin, C; Lin, Q; Zhang, Y; Zheng, X; Zhou, Y | 1 |
Fiore, A; Fogliano, V; Troise, AD; Wiltafsky, M | 1 |
Battú, CE; Broetto, N; Dutra, MF; Galland, F; Gonçalves, CA; Hansen, F; Lirio, F; Nardin, P | 1 |
Alam, K; Ali, A; Habib, S; Khan, F; Mir, AR | 1 |
Fiore, A; Troise, AD; Tsang, C; Vitiello, D | 1 |
Mildner-Szkudlarz, S; Przygoński, K; Siger, A; Szwengiel, A; Wojtowicz, E; Zawirska-Wojtasiak, R | 1 |
Chen, J; He, J; Jiao, Y; Li, F; Qin, F; Tao, G; Zeng, M; Zhang, S | 1 |
Arakawa, S; Ichimaru, K; Kabata, K; Kinoshita, S; Matsuda, S; Nagai, M; Nagai, R; Ohno, RI; Shirakawa, JI; Sugawa, H | 1 |
Barandalla, M; Colleoni, S; Fischer, B; Galli, C; Haucke, E; Lazzari, G; Navarrete Santos, A | 1 |
Fogliano, V; Troise, AD; Vitaglione, P; Wiltafsky, M | 1 |
1 trial(s) available for lysine and n(6)-(1-carboxyethyl)lysine
Article | Year |
---|---|
Irbesartan treatment does not influence plasma levels of the advanced glycation end products N(epsilon)(1-carboxymethyl)lysine and N(epsilon)(1-carboxyethyl)lysine in patients with type 2 diabetes and microalbuminuria. A randomized controlled trial.
Topics: Adult; Aged; Albuminuria; Angiotensin Receptor Antagonists; Biomarkers; Biphenyl Compounds; Diabetes Complications; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glycation End Products, Advanced; Humans; Hypertension; Irbesartan; Lysine; Male; Middle Aged; Prognosis; Tetrazoles | 2011 |
52 other study(ies) available for lysine and n(6)-(1-carboxyethyl)lysine
Article | Year |
---|---|
N6-(1-carboxyethyl)lysine formation by Streptococcus lactis. Purification, synthesis, and stereochemical structure.
Topics: Amino Acids; Chromatography, Thin Layer; Lactococcus lactis; Lysine; Magnetic Resonance Spectroscopy; Stereoisomerism | 1988 |
Carboxyethyllysine in a protein: native carbonyl reductase/NADP(+)-dependent prostaglandin dehydrogenase.
Topics: Alcohol Oxidoreductases; Aldehyde Reductase; Aldo-Keto Reductases; Amino Acid Sequence; Female; Humans; Hydroxysteroid Dehydrogenases; Isoenzymes; Lysine; Models, Molecular; Molecular Sequence Data; Placenta; Prostaglandins; Protein Conformation; Protein Structure, Secondary; Sequence Analysis; Sequence Homology, Amino Acid | 1993 |
N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Carbohydrate Metabolism; Child; Collagen; Crystallins; Humans; Lens, Crystalline; Lysine; Middle Aged; Oxidative Stress; Pyruvaldehyde; Ribonucleases; Skin | 1997 |
Structure of the O-specific polysaccharide of the bacterium Providencia alcalifaciens O23 containing a novel component: an amide of D-glucuronic acid with N(epsilon)-(1-carboxyethyl)lysine.
Topics: Amides; Carbohydrate Conformation; Carbohydrate Sequence; Glucuronates; Glucuronic Acid; Lysine; Magnetic Resonance Spectroscopy; Molecular Sequence Data; O Antigens; Providencia | 1997 |
Structure of the O-specific polysaccharide of the bacterium Proteus mirabilis O13 containing a novel component: an amide of D-galacturonic acid with N(epsilon)-(1-carboxyethyl)lysine.
Topics: Amides; Carbohydrate Conformation; Carbohydrate Sequence; Hexuronic Acids; Lysine; Magnetic Resonance Spectroscopy; Molecular Sequence Data; O Antigens; Proteus mirabilis | 1997 |
Identification of N epsilon-[(R)-1-carboxyethyl]-L-lysine in, and the complete structure of, the repeating unit of the O-specific polysaccharide of Providencia alcalifaciens O23.
Topics: Carbohydrate Conformation; Carbohydrate Sequence; Gas Chromatography-Mass Spectrometry; Lysine; Mass Spectrometry; Molecular Sequence Data; Nuclear Magnetic Resonance, Biomolecular; O Antigens; Oligosaccharides; Optical Rotation; Providencia | 1998 |
Age-related accumulation of Maillard reaction products in human articular cartilage collagen.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Aging; Arginine; Cartilage, Articular; Child; Child, Preschool; Collagen; Collagenases; Cross-Linking Reagents; Female; Femur; Glycation End Products, Advanced; Humans; Lysine; Maillard Reaction; Male; Middle Aged; Skin; Spectrometry, Fluorescence | 2000 |
Effect of collagen turnover on the accumulation of advanced glycation end products.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Arginine; Aspartic Acid; Cartilage, Articular; Child; Child, Preschool; Chondrocytes; Collagen; Glycation End Products, Advanced; Humans; Kinetics; Lysine; Middle Aged; Skin | 2000 |
Assay of advanced glycation endproducts (AGEs): surveying AGEs by chromatographic assay with derivatization by 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and application to Nepsilon-carboxymethyl-lysine- and Nepsilon-(1-carboxyethyl)lysine-modified a
Topics: Aminoquinolines; Biochemistry; Carbamates; Chromatography; Chromatography, High Pressure Liquid; Glucose; Glycation End Products, Advanced; Indicators and Reagents; Lysine; Magnetic Resonance Spectroscopy; Models, Chemical; Temperature; Time Factors | 2002 |
Aging increases Nepsilon-(carboxymethyl)lysine and caloric restriction decreases Nepsilon-(carboxyethyl)lysine and Nepsilon-(malondialdehyde)lysine in rat heart mitochondrial proteins.
Topics: Aging; Animals; Enzyme-Linked Immunosorbent Assay; Fatty Acids; Food Deprivation; Gas Chromatography-Mass Spectrometry; Lysine; Male; Malondialdehyde; Mitochondria; Models, Statistical; Myocardium; Oxidative Stress; Phospholipids; Rats; Rats, Wistar; Reactive Oxygen Species; Time Factors | 2002 |
Oxidative, glycoxidative and lipoxidative damage to rat heart mitochondrial proteins is lower after 4 months of caloric restriction than in age-matched controls.
Topics: Aldehydes; Animals; Biomarkers; Energy Intake; Glutamates; Lysine; Male; Mitochondria, Heart; Mitochondrial Proteins; Oxidative Stress; Rats; Rats, Wistar; Reference Values; Time Factors | 2002 |
Identification of N epsilon-(carboxyethyl)lysine, one of the methylglyoxal-derived AGE structures, in glucose-modified protein: mechanism for protein modification by reactive aldehydes.
Topics: Aldehydes; Chromatography, High Pressure Liquid; Glucose; Glycation End Products, Advanced; Lysine; Maillard Reaction; Pyruvaldehyde; Serum Albumin, Bovine | 2003 |
Increased levels of N(epsilon)-(carboxymethyl)lysine and N(epsilon)-(carboxyethyl)lysine in type 1 diabetic patients with impaired renal function: correlation with markers of endothelial dysfunction.
Topics: Adult; Aged; Blood Coagulation Factors; C-Reactive Protein; Case-Control Studies; Diabetes Mellitus, Type 1; E-Selectin; Endothelium, Vascular; Female; Glomerular Filtration Rate; Humans; Kidney; Lysine; Male; Middle Aged; Thrombomodulin; Vascular Cell Adhesion Molecule-1 | 2004 |
Nepsilon-(carboxymethyl)lysine, Nepsilon-(carboxyethyl)lysine and vascular cell adhesion molecule-1 (VCAM-1) in relation to peritoneal glucose prescription and residual renal function; a study in peritoneal dialysis patients.
Topics: Cross-Sectional Studies; Female; Glomerular Filtration Rate; Glucose; Glycation End Products, Advanced; Humans; Kidney Failure, Chronic; Lysine; Male; Middle Aged; Peritoneal Dialysis; Vascular Cell Adhesion Molecule-1 | 2004 |
Measurement of Nepsilon-(carboxymethyl)lysine and Nepsilon-(carboxyethyl)lysine in human plasma protein by stable-isotope-dilution tandem mass spectrometry.
Topics: Biomarkers; Blood Proteins; Chromatography, Liquid; Glycation End Products, Advanced; Humans; Hydrolysis; Indicator Dilution Techniques; Lipids; Lysine; Mass Spectrometry; Oxidation-Reduction; Renal Dialysis; Renal Insufficiency | 2004 |
The clinical chemome: a tool for the diagnosis and management of chronic disease.
Topics: Biomarkers; Chromatography, Liquid; Chronic Disease; Glycation End Products, Advanced; Humans; Lipid Metabolism; Lipids; Lysine; Mass Spectrometry; Oxidation-Reduction; Renal Dialysis; Renal Insufficiency | 2004 |
Elevated serum levels of N(epsilon)-carboxymethyl-lysine, an advanced glycation end product, are associated with proliferative diabetic retinopathy and macular oedema.
Topics: Biomarkers; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Glycation End Products, Advanced; Humans; Hypoglycemic Agents; Lysine; Macular Degeneration; Male; Middle Aged | 2004 |
Conventional antibody against Nepsilon-(carboxymethyl)lysine (CML) shows cross-reaction to Nepsilon-(carboxyethyl)lysine (CEL): immunochemical quantification of CML with a specific antibody.
Topics: Animals; Antibodies, Monoclonal; Cattle; Cross Reactions; Eye Proteins; Glycation End Products, Advanced; Immunization; Immunoglobulin G; Lysine; Rabbits; Serum Albumin, Bovine | 2004 |
Rapid and simple method for determination of Nepsilon-(carboxymethyl)lysine and Nepsilon-(carboxyethyl)lysine in urine using gas chromatography/mass spectrometry.
Topics: Child; Gas Chromatography-Mass Spectrometry; Glycation End Products, Advanced; Humans; Lysine; Reproducibility of Results; Time Factors | 2005 |
Advanced glycation end products are associated with pulse pressure in type 1 diabetes: the EURODIAB Prospective Complications Study.
Topics: Adult; Blood Pressure; Case-Control Studies; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Linear Models; Lysine; Male; Middle Aged; Multicenter Studies as Topic; Platelet Activating Factor; Prospective Studies | 2005 |
epsilon-Glycation, APP and Abeta in ageing and Alzheimer disease: a hypothesis.
Topics: Aging; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Brain; Glycation End Products, Advanced; Humans; Lysine; Models, Neurological | 2006 |
Advanced glycation end product deposits in climatic droplet keratopathy.
Topics: Antibodies, Monoclonal; Arginine; Cornea; Corneal Diseases; Cross-Linking Reagents; Female; Glycation End Products, Advanced; Humans; Immunohistochemistry; Lysine; Male; Middle Aged; Pyrroles | 2007 |
Advanced glycation end products and the absence of premature atherosclerosis in glycogen storage disease Ia.
Topics: Adolescent; Adult; Arginine; Atherosclerosis; Carotid Arteries; Collagen; Female; Glycation End Products, Advanced; Glycogen Storage Disease Type I; Humans; Lysine; Male; Oxidative Stress; Risk; Skin; Tunica Intima; Tunica Media | 2007 |
Clinical and prognostic value of advanced glycation end-products in chronic heart failure.
Topics: Aged; Biomarkers; Female; Follow-Up Studies; Glycation End Products, Advanced; Heart Failure; Humans; Lysine; Male; Middle Aged; Prognosis; Risk Assessment; Risk Factors; Survival Analysis | 2007 |
Skin autofluorescence is increased in systemic lupus erythematosus but is not reflected by elevated plasma levels of advanced glycation endproducts.
Topics: Adult; Case-Control Studies; Female; Fluorescence; Glycation End Products, Advanced; Humans; Lupus Erythematosus, Systemic; Lysine; Male; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Severity of Illness Index; Skin; Vascular Cell Adhesion Molecule-1 | 2008 |
Methylglyoxal production in vascular smooth muscle cells from different metabolic precursors.
Topics: Acetone; Animals; Aorta; Cell Line; Fructose; Glucose; Lysine; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nitrates; Nitric Oxide; Nitric Oxide Synthase Type II; Nitrites; Peroxynitrous Acid; Pyruvaldehyde; Rats | 2008 |
Association between carotid diameter and the advanced glycation end product N-epsilon-carboxymethyllysine (CML).
Topics: Adult; alpha-2-HS-Glycoprotein; Anthropometry; Belgium; Biomarkers; Blood Proteins; Carotid Arteries; Carotid Artery Diseases; Cohort Studies; Elasticity; Female; Glycation End Products, Advanced; Humans; Hypertension; Inflammation; Lysine; Male; Mechanotransduction, Cellular; Middle Aged; Sampling Studies; Tunica Intima; Ultrasonography | 2009 |
Characterization of anti-advanced glycation end product antibodies to nonenzymatically lysine-derived and arginine-derived glycated products.
Topics: Animals; Antibodies; Arginine; Cattle; Cross Reactions; Glycation End Products, Advanced; Lysine; Rabbits; Serum Albumin, Bovine | 2009 |
Association of polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating RAGE levels.
Topics: Aged; Blotting, Western; Cohort Studies; Creatine; Enzyme-Linked Immunosorbent Assay; Female; Gene Frequency; Glycation End Products, Advanced; Humans; Kidney Function Tests; Lysine; Male; Middle Aged; Netherlands; Phenotype; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Receptor for Advanced Glycation End Products; Receptors, Immunologic | 2009 |
Plasma levels of advanced glycation end products are associated with haemolysis-related organ complications in sickle cell patients.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Arginine; Biomarkers; Female; Glycation End Products, Advanced; Hemolysis; Humans; Lysine; Male; Middle Aged; Oxidative Stress; Young Adult | 2010 |
Advanced glycation end products in diabetic and non-diabetic human subjects suffering from cataract.
Topics: Aged; beta-Crystallins; Cataract; Diabetes Mellitus, Type 2; Female; Glycation End Products, Advanced; Humans; Immunohistochemistry; Lens, Crystalline; Lysine; Male; Middle Aged | 2011 |
Effect of inhibitor compounds on Nε-(carboxymethyl)lysine (CML) and Nε-(carboxyethyl)lysine (CEL) formation in model foods.
Topics: Food Analysis; Food Handling; Lysine | 2010 |
An autoantibody against N(ε)-(carboxyethyl)lysine (CEL): possible involvement in the removal of CEL-modified proteins by macrophages.
Topics: Animals; Arginine; Autoantibodies; Glycation End Products, Advanced; Humans; Lysine; Macrophages, Peritoneal; Mice; Rabbits; Serum Albumin | 2011 |
Structure of the O-polysaccharide of Providencia alcalifaciens O25 containing an amide of D-galacturonic acid with N(ε)-[(R)-1-carboxyethyl]-L-lysine.
Topics: Amides; Carbohydrate Sequence; Hexuronic Acids; Lysine; Magnetic Resonance Spectroscopy; Molecular Sequence Data; O Antigens; Optical Rotation; Providencia | 2011 |
Ellagic acid, a new antiglycating agent: its inhibition of Nϵ-(carboxymethyl)lysine.
Topics: Animals; Crystallins; Diabetes Complications; Ellagic Acid; Gluconates; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Lactones; Lens, Crystalline; Lysine; Male; Muramidase; Organ Culture Techniques; Rats; Rats, Wistar; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2012 |
Plasma glycation levels are associated with severity in sepsis.
Topics: Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Female; Glycation End Products, Advanced; Humans; Kidney Diseases; Lysine; Male; Middle Aged; Prognosis; ROC Curve; Sepsis | 2012 |
The effects of low-dose nepsilon-(carboxymethyl)lysine (CML) and nepsilon-(carboxyethyl)lysine (CEL), two main glycation free adducts considered as potential uremic toxins, on endothelial progenitor cell function.
Topics: Apoptosis; Cell Movement; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells; Glycation End Products, Advanced; Humans; Lysine; Mitogen-Activated Protein Kinases; Neovascularization, Physiologic; Phosphorylation; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Stem Cells; Time Factors; Toxins, Biological; Uremia | 2012 |
Gentamicin caused renal injury deeply related to methylglyoxal and N(ɛ)-(carboxyethyl)lysine (CEL).
Topics: Animals; Anti-Bacterial Agents; Antioxidants; Gentamicins; Glutathione; Immunohistochemistry; Kidney Diseases; Kidney Function Tests; Lysine; Male; Metformin; Pyruvaldehyde; Rats; Rats, Wistar | 2013 |
Synthesis of stable isotope-labelled monolysyl advanced glycation endproducts.
Topics: Diabetes Mellitus; Glycation End Products, Advanced; Isotope Labeling; Lysine; Mass Spectrometry; Norleucine; Pyrroles | 2013 |
Plasma advanced glycation end-products and skin autofluorescence are increased in COPD.
Topics: Aged; Arginine; Case-Control Studies; Female; Fluorescence; Glycation End Products, Advanced; Humans; Inflammation; Lung; Lysine; Male; Middle Aged; Oxidative Stress; Pulmonary Disease, Chronic Obstructive; Skin; Smoking; Spirometry | 2014 |
Plasma levels of advanced glycation endproducts Nε-(carboxymethyl)lysine, Nε-(carboxyethyl)lysine, and pentosidine are not independently associated with cardiovascular disease in individuals with or without type 2 diabetes: the Hoorn and CODAM studies.
Topics: Aged; Arginine; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Glucose; Humans; Lysine; Male; Middle Aged | 2013 |
Isotope dilution ESI-LC-MS/MS for quantification of free and total Nε-(1-Carboxymethyl)-L-Lysine and free Nε-(1-Carboxyethyl)-L-Lysine: comparison of total Nε-(1-Carboxymethyl)-L-Lysine levels measured with new method to ELISA assay in gruel samples.
Topics: Beverages; Chromatography, Liquid; Enzyme-Linked Immunosorbent Assay; Glycation End Products, Advanced; Isotope Labeling; Lysine; Tandem Mass Spectrometry | 2013 |
Simultaneous analysis of N(ε) -(carboxymethyl)Lysine and N(ε) -(carboxyethyl)lysine in foods by ultra-performance liquid chromatography-mass spectrometry with derivatization by 9-fluorenylmethyl chloroformate.
Topics: Chromatography, Liquid; Fluorenes; Food Analysis; Glycation End Products, Advanced; Humans; Indicators and Reagents; Lysine; Mass Spectrometry; Reproducibility of Results | 2015 |
Quantification of Nε-(2-Furoylmethyl)-L-lysine (furosine), Nε-(Carboxymethyl)-L-lysine (CML), Nε-(Carboxyethyl)-L-lysine (CEL) and total lysine through stable isotope dilution assay and tandem mass spectrometry.
Topics: Chromatography, Liquid; Food Analysis; Indicator Dilution Techniques; Isotopes; Lysine; Protein Conformation; Quality Control; Reproducibility of Results; Tandem Mass Spectrometry | 2015 |
Methylglyoxal and carboxyethyllysine reduce glutamate uptake and S100B secretion in the hippocampus independently of RAGE activation.
Topics: Animals; Astrocytes; Biological Transport; Diabetes Mellitus; Energy Metabolism; Glucose; Glutamate-Ammonia Ligase; Glutamic Acid; Hippocampus; Hyperglycemia; Lysine; Male; Oxidation-Reduction; Pyruvaldehyde; Rats; Rats, Wistar; Reactive Oxygen Species; Receptor for Advanced Glycation End Products; S100 Calcium Binding Protein beta Subunit | 2016 |
Structural changes in histone H2A by methylglyoxal generate highly immunogenic amorphous aggregates with implications in auto-immune response in cancer.
Topics: Adolescent; Adult; Animals; Antibodies, Neoplasm; Autoantibodies; Case-Control Studies; Epitopes; Female; Gastrointestinal Neoplasms; Histones; Humans; Lung Neoplasms; Lysine; Male; Middle Aged; Prostatic Neoplasms; Pyruvaldehyde; Rabbits | 2016 |
Encapsulation of ascorbic acid promotes the reduction of Maillard reaction products in UHT milk.
Topics: Animals; Ascorbic Acid; Food Handling; Food, Fortified; Glycation End Products, Advanced; Lysine; Maillard Reaction; Mass Spectrometry; Milk | 2016 |
Phenolic compounds reduce formation of N
Topics: Bread; Catechin; Lysine; Maillard Reaction; Phenols; Pyrazines | 2017 |
N
Topics: Glycation End Products, Advanced; Lysine; Tandem Mass Spectrometry; Tea | 2017 |
Aphanothece sacrum (Sur.) Okada Prevents Cataractogenesis in Type 1 Diabetic Mice.
Topics: Animals; Biomarkers; Cataract; Cyanobacteria; Diabetes Mellitus, Experimental; Diet; Freeze Drying; Lens, Crystalline; Lysine; Male; Mice; Oxidative Stress | 2017 |
Comparative Analysis of AGE and RAGE Levels in Human Somatic and Embryonic Stem Cells under H
Topics: Antigens, Neoplasm; Cell Differentiation; Cell Line; Embryonic Stem Cells; Fibroblasts; Glycation End Products, Advanced; Human Umbilical Vein Endothelial Cells; Humans; Hydrogen Peroxide; Lysine; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; Neural Stem Cells; Neurons; Oxidative Stress; RNA, Messenger | 2017 |
The quantification of free Amadori compounds and amino acids allows to model the bound Maillard reaction products formation in soybean products.
Topics: Amino Acids; Discriminant Analysis; Food Analysis; Food Handling; Glycation End Products, Advanced; Glycine max; Lysine; Maillard Reaction; Mass Spectrometry; Plant Proteins | 2018 |